ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

In Brief: Clarkson, Freireich Head AACR, ASCO; Oncology Nursing Society Membership Total Now 2,369

June 6, 1980

Cancer.gov Knocked Offline By Theft Of Routers

July 11, 2003

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978